Secretome STM-01 Duchenne Cardiomyopathy | Lucid Diligence Brief
Secretome’s STM-01 faces Duchenne cardiomyopathy endpoint, CMC, and regulatory…
Cell and Gene Therapy Today—October 23, 2025
This week’s Cell and Gene Therapy update spotlights key developments,…
Lucid Diligence Brief: Kardigan $254m Series B
Lucid Diligence Brief: Kardigan $254m Series B Professional audiences only. Not…
ASGCT 2025 PREVIEW: Key Cell and Gene Therapy Highlights to Watch
ASGCT 2025 at a glance Count down to ASGCT 2025 with LucidQuest’s brief…
ACC 2025 Preview: Key Cardiology Highlights to Watch
ACC at a glance In the lead-up to ACC 2025, LucidQuest outlines the key…